Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Other Non-Current Assets of $18.8 million for Q1 2026, up 376.74% year-over-year from $3.9 million in Q1 2025, and down 2.59% quarter-over-quarter from $19.3 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $18.8 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 376.74% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (up 376.74% YoY), while the FY2025 annual figure was $99.5 million, up 1267.18% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $18.8 million, down from $19.3 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $99.5 million in Q2 2025, with the low at $623000.0 in Q3 2024.
- The 5-year median for Other Non-Current Assets is $8.0 million (2023), against an average of $18.2 million.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets tumbled 98.03% in 2022, then surged 2963.56% in 2025.
- Phibro Animal Health's Other Non-Current Assets stood at $7.6 million in 2022, then jumped by 951.19% to $79.6 million in 2023, then plunged by 80.2% to $15.8 million in 2024, then gained by 22.52% to $19.3 million in 2025, then declined by 2.59% to $18.8 million in 2026.
- Business Quant data shows PAHC's Other Non-Current Assets at $18.8 million in Q1 2026, $19.3 million in Q4 2025, and $19.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 100.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.82 Mn |
| Dec 31, 2025 | 19.32 Mn |
| Sep 30, 2025 | 19.09 Mn |
| Jun 30, 2025 | 99.49 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Sep 30, 2024 | 623,000.00 |
| Jun 30, 2024 | 7.28 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 79.64 Mn |
| Sep 30, 2023 | 7.79 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 8.52 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 8.77 Mn |
| Dec 31, 2021 | 5.24 Mn |
| Sep 30, 2021 | 8.53 Mn |
| Jun 30, 2021 | 72.75 Mn |